The Evolution Of GLP-1s: Overcoming Clinical Development Challenges

GLP-1 receptor agonists have transformed the treatment landscape for obesity and metabolic disease, creating new opportunities — and new challenges — for clinical development. As interest in these therapies continues to expand, researchers must navigate increasingly complex trial designs, patient recruitment considerations, evolving endpoints, and heightened competition for study participants.

This webinar explores the current state of the GLP-1 market and examines key factors shaping successful metabolic clinical research programs. Learn how sponsors can address operational hurdles, identify appropriate patient populations, and design studies that generate meaningful data in a rapidly advancing therapeutic area. Insights also highlight the growing role of GLP-1 therapies beyond weight management, including their potential impact across a broader range of metabolic and chronic health conditions.

For organizations developing next-generation metabolic treatments, understanding the clinical, regulatory, and operational dynamics influencing GLP-1 research is critical. Access the webinar to gain practical perspectives on trends, challenges, and strategies that can help support more efficient and effective clinical development.